
### [MONDO:0002108](http://purl.obolibrary.org/obo/MONDO_0002108)
**Label:** thyroid cancer

**Subclasses:** [MONDO:0017896](http://purl.obolibrary.org/obo/MONDO_0017896) (familial nonmedullary thyroid carcinoma), [MONDO:0015423](http://purl.obolibrary.org/obo/MONDO_0015423) (anaplastic thyroid carcinoma (disease)), [MONDO:0019962](http://purl.obolibrary.org/obo/MONDO_0019962) (thyroid lymphoma), [MONDO:0014681](http://purl.obolibrary.org/obo/MONDO_0014681) (thyroid cancer, nonmedullary, 4), [MONDO:0014682](http://purl.obolibrary.org/obo/MONDO_0014682) (thyroid cancer, nonmedullary, 5), [MONDO:0019003](http://purl.obolibrary.org/obo/MONDO_0019003) (multiple endocrine neoplasia type 2), [MONDO:0017895](http://purl.obolibrary.org/obo/MONDO_0017895) (familial papillary or follicular thyroid carcinoma), [MONDO:0015277](http://purl.obolibrary.org/obo/MONDO_0015277) (medullary thyroid gland carcinoma), [MONDO:0008566](http://purl.obolibrary.org/obo/MONDO_0008566) (thyroid cancer, nonmedullary, 2), [MONDO:0015075](http://purl.obolibrary.org/obo/MONDO_0015075) (thyroid carcinoma (disease)), [MONDO:0008567](http://purl.obolibrary.org/obo/MONDO_0008567) (thyroid cancer, nonmedullary, 1), [MONDO:0007958](http://purl.obolibrary.org/obo/MONDO_0007958) (familial medullary thyroid carcinoma), [MONDO:0011836](http://purl.obolibrary.org/obo/MONDO_0011836) (thyroid Hurthle cell carcinoma), [MONDO:0011578](http://purl.obolibrary.org/obo/MONDO_0011578) (familial papillary thyroid carcinoma with renal papillary neoplasia), [MONDO:0011368](http://purl.obolibrary.org/obo/MONDO_0011368) (papillary thyroid Microcarcinoma), [MONDO:0011312](http://purl.obolibrary.org/obo/MONDO_0011312) (thyroid carcinoma, nonmedullary, with or without cell oxyphilia), [MONDO:0011653](http://purl.obolibrary.org/obo/MONDO_0011653) (NMTC3), [MONDO:0015447](http://purl.obolibrary.org/obo/MONDO_0015447) (differentiated thyroid carcinoma), [MONDO:0008082](http://purl.obolibrary.org/obo/MONDO_0008082) (multiple endocrine neoplasia type 2B), 

**Corr. equiv. classes:** [OMIM:162300](http://purl.obolibrary.org/obo/OMIM_162300), [Orphanet:146](http://www.orpha.net/ORDO/Orphanet_146), [OMIM:603386](http://purl.obolibrary.org/obo/OMIM_603386), [OMIM:605642](http://purl.obolibrary.org/obo/OMIM_605642), [OMIM:603744](http://purl.obolibrary.org/obo/OMIM_603744), [Orphanet:142](http://www.orpha.net/ORDO/Orphanet_142), [Orphanet:97285](http://www.orpha.net/ORDO/Orphanet_97285), [Orphanet:99361](http://www.orpha.net/ORDO/Orphanet_99361), [Orphanet:100088](http://www.orpha.net/ORDO/Orphanet_100088), [OMIM:155240](http://purl.obolibrary.org/obo/OMIM_155240), [OMIM:188550](http://purl.obolibrary.org/obo/OMIM_188550), [OMIM:188470](http://purl.obolibrary.org/obo/OMIM_188470), [Orphanet:97290](http://www.orpha.net/ORDO/Orphanet_97290), [OMIM:616534](http://purl.obolibrary.org/obo/OMIM_616534), [Orphanet:1332](http://www.orpha.net/ORDO/Orphanet_1332), [OMIM:616535](http://purl.obolibrary.org/obo/OMIM_616535), [Orphanet:319494](http://www.orpha.net/ORDO/Orphanet_319494), [OMIM:607464](http://purl.obolibrary.org/obo/OMIM_607464), [Orphanet:247709](http://www.orpha.net/ORDO/Orphanet_247709), [Orphanet:319487](http://www.orpha.net/ORDO/Orphanet_319487), [Orphanet:653](http://www.orpha.net/ORDO/Orphanet_653), [OMIM:606240](http://purl.obolibrary.org/obo/OMIM_606240), 

**Class expressions from DL-Learner:**

- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology))) 62.08%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 60.00%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0100733](http://purl.obolibrary.org/obo/HP_0100733) (Neoplasm of the parathyroid gland))) 59.58%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0002897](http://purl.obolibrary.org/obo/HP_0002897) (Parathyroid adenoma))) 58.85%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin))) 57.95%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0002574](http://purl.obolibrary.org/obo/HP_0002574) (Episodic abdominal pain))) 57.52%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0000845](http://purl.obolibrary.org/obo/HP_0000845) (Growth hormone excess))) 57.52%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 56.94%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system))) 55.98%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument))) 55.98%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) 55.28%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 55.28%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 55.28%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 55.28%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 55.28%


